- Home
- SCYX vs EBON Comparison
SCYX vs EBON Comparison
Compare SCYX & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- EBON
- Stock Information
- Founded
- SCYX 1999
- EBON 2010
- Country
- SCYX United States
- EBON China
- Employees
- SCYX N/A
- EBON N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- EBON Semiconductors
- Sector
- SCYX Health Care
- EBON Technology
- Exchange
- SCYX Nasdaq
- EBON Nasdaq
- Market Cap
- SCYX 28.5M
- EBON 25.3M
- IPO Year
- SCYX 2014
- EBON 2020
- Fundamental
- Price
- SCYX $0.71
- EBON $3.37
- Analyst Decision
- SCYX
- EBON
- Analyst Count
- SCYX 0
- EBON 0
- Target Price
- SCYX N/A
- EBON N/A
- AVG Volume (30 Days)
- SCYX 115.9K
- EBON 9.0K
- Earning Date
- SCYX 08-07-2025
- EBON 08-22-2025
- Dividend Yield
- SCYX N/A
- EBON N/A
- EPS Growth
- SCYX N/A
- EBON N/A
- EPS
- SCYX N/A
- EBON N/A
- Revenue
- SCYX $2,630,000.00
- EBON $5,868,771.00
- Revenue This Year
- SCYX $463.61
- EBON N/A
- Revenue Next Year
- SCYX $310.80
- EBON N/A
- P/E Ratio
- SCYX N/A
- EBON N/A
- Revenue Growth
- SCYX N/A
- EBON 20.88
- 52 Week Low
- SCYX $0.66
- EBON $3.00
- 52 Week High
- SCYX $2.29
- EBON $10.94
- Technical
- Relative Strength Index (RSI)
- SCYX 39.58
- EBON 42.44
- Support Level
- SCYX $0.70
- EBON $3.17
- Resistance Level
- SCYX $0.75
- EBON $3.60
- Average True Range (ATR)
- SCYX 0.05
- EBON 0.23
- MACD
- SCYX 0.00
- EBON -0.00
- Stochastic Oscillator
- SCYX 28.80
- EBON 31.59
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.